期刊文献+

人血白蛋白与晶体液对成人脓毒症及脓毒症休克患者液体复苏作用Meta分析 被引量:10

Albumin vs. Crystalloids in Fluid Resuscitation for Adults with Severe Spesis and Septic Shock: a Meta-analysis
下载PDF
导出
摘要 目的系统评价使用人血白蛋白与晶体液对成人脓毒症及脓毒症休克患者液体复苏作用的影响。方法采用计算机检索Cochrane Library、Pubmed、Embase、中国期刊全文数据库(CNKI)、维普中文科技期刊全文数据库(VIP)、万方数据库,检索时间从建库至2015年11月,对符合纳入标准的随机对照试验(RCT)进行质量评价,并采用Rev Man5.3版软件进行Meta分析。结果共纳入4项RCT,合计患者3 862例。人血白蛋白和晶体液对患者28 d死亡率[RR=0.95,95%CI(0.86,1.05),P=0.33]、90 d死亡率[RR=0.95,95%CI(0.86,1.05),P=0.33]、重症监护室住院时间、总住院时间、机械通气时间、肾脏替代治疗等结局指标的影响均差异无统计学意义。结论人血白蛋白和晶体液作为复苏液体,对成人脓毒症或脓毒症休克患者的预后差异无统计学意义。 Objective To systematically evaluate the effects of albumin compared with crystalloids on fluid resuscitation for adults with severe sepsis and septic shock. Methods The six databases as follows:Cochrane Library,Pubmed,Embase,CNKI,VIP and Wanfang,were retrieved by computer,from their inception to November,2015.Randomized controlled trials(RCT) in the treatment of adult patients with severe sepsis and septic shock were included for quality assessment and Meta-analysis was performed by using RevMan5.3 software. Results A total of 4 RCTs involving 3 862 participants were included.No differences were found between albumin and crystalloids resuscitation with respect to 28-day mortality[RR=0.95,95%CI(0.86,1.05),P=0.33],90-day mortality[RR=0.95,95%CI(0.86,1.05),P=0.33],duration of stay in ICU,duration of hospital stay,duration of mechanical ventilation and renal replacement therapy. Conclusion In that meta-analysis,the effects of fluid resuscitation with albumin or crystalloids were not significantly different in adults with severe sepsis and septic shock.
出处 《医药导报》 CAS 2017年第7期804-808,共5页 Herald of Medicine
基金 上海医院药学科研基金资助项目(2014-YY-03-06)
关键词 白蛋白 晶体液 脓毒症 液体复苏 META分析 Albumin Crystalloids Severe sepsis Fluid resuscitation Meta-analysis
  • 相关文献

参考文献2

二级参考文献85

  • 1Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Cam- paign : international guidelines for management of severe sepsis and septic shock, 2012 [ J ]. Intensive Care Med, 2013, 39 (2) : 165 - 228.
  • 2Kumar G, Kumar N, Taneja A, et al. Nationwide trends of severe sepsis in the 21st century (2000 -2007) [J]. Chest, 2011, 140 (5) : 1223 -1231.
  • 3Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sep- sis Campaign: results of an international guideline - based per- formance improvement program targeting severe sepsis [ J ]. Inten- sive Care Med, 2010, 36(2) : 222 -231.
  • 4Lam SW, Bauer SR, Guzman JA, et al. Septic shock: the initial moments and beyond [ J ]. Cleve Clin J Med, 2013, 80 ( 3 ) : 175 - 184.
  • 5Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta - analysis [ J ]. Lancet Infect Dis, 2007, 7 (3) : 210 - 217.
  • 6Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactateclearance as a determinant of survival in patients with presumedsepsis[ J]. Shock, 2009, 32( 1 ): 35- 39.
  • 7Pierrakos C, Vincent JL. Sepsis biomarkers: a review [ J ]. Crit Care, 2010, 14(1) : R15.
  • 8Shapiro NI, Trzeciak S, Hollander JE, et al. A prospective, mul- ticenter derivation of a biomarker panel to assess risk of organ dys- function, shock, and death in emergency department patients with suspected sepsis[ J]. Crit Care Med, 2009, 37 ( 1 ) : 96 - 104.
  • 9Henriquez - Camacho C, Losa J. Biomarkers for Sepsis [ J ]. Biomed Res Int, 2014, 2014:547 -818.
  • 10Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis : a multiplex analysis [ J ]. Crit Care, 2007, 11 ( 2 ) : R49.

共引文献17

同被引文献75

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部